Use of Serum Cystatin C to Detect Early Decline of Glomerular Filtration Rate in Type 2 Diabetes

Abstract

These results suggest that serum cystatin C may be an alternative serum marker for the early identification of subjects with a slight reduction of renal function, and also it may be a marker for early glomerular dysfunction in type 2 diabetes.